Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs ...

Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance ...

The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...